{"name":"Amarantus BioScience Holdings, Inc.","slug":"amarantus-bioscience-holdings-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":13256000,"netIncome":-25214000,"cash":176000,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2014"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Dermatology","slug":"dermatology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Autologous Engineered Skin Substitute","genericName":"Autologous Engineered Skin Substitute","slug":"autologous-engineered-skin-substitute","indication":"Burns, wounds, and other skin injuries","status":"phase_2"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Eltoprazine HCl","genericName":"Eltoprazine HCl","slug":"eltoprazine-hcl","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"Autologous Engineered Skin Substitute","genericName":"Autologous Engineered Skin Substitute","slug":"autologous-engineered-skin-substitute","phase":"phase_2","mechanism":"Autologous Engineered Skin Substitute is a regenerative medicine that uses a patient's own cells to promote skin healing.","indications":["Burns, wounds, and other skin injuries"],"catalyst":""},{"name":"Eltoprazine HCl","genericName":"Eltoprazine HCl","slug":"eltoprazine-hcl","phase":"phase_2","mechanism":"Eltoprazine modulates serotonin receptors in the brain, particularly acting as an agonist at 5-HT1A and 5-HT1B receptors.","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiaEFVX3lxTE9SY1ViQ01sTG5MT0IweGU0Vm1KWDFoRjBMbjdZZUR5d2xROU45bk1TRXYxS1hLT1Q4cXdncW9NeWFoWHZTcHY5VzM5TEU2dGpXa1RILWNCdFZZLUtzZjJVRHZSaExZOTg5?oc=5","date":"2026-04-04","type":"pipeline","source":"Yahoo! Finance Canada","summary":"Oncology Pharma Inc. (ONPH) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada","headline":"Oncology Pharma Inc. (ONPH) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada","sentiment":"neutral"},{"date":"2020-10-09","type":"earnings","source":"SEC EDGAR","summary":"SC 13D filed with SEC: SC 13D","headline":"SC 13D Filing","sentiment":"neutral"},{"date":"2020-10-05","type":"earnings","source":"SEC EDGAR","summary":"SC 13D filed with SEC: SC 13D","headline":"SC 13D Filing","sentiment":"neutral"},{"date":"2020-10-05","type":"earnings","source":"SEC EDGAR","summary":"SC 13D filed with SEC: SC 13D","headline":"SC 13D Filing","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1wFBVV95cUxNYXJOYU5pMWZHNEdRZzdhVjV2UjRVVHNqQW9CZVQyNXU2V3BIQldrZ3lqd2pKbnAyUVZKM3ZJRWMtbWZQRkpxZ1Z6UnlmY09EYWtqckdmVGhoN0NtT1VSYV9YTjAyMEU4M0t1MlZLYmxoeVZHWlozUmV3YUlpTGpkcVQ1bVZNbkJ2N3hjaTFGOXRSQ1cwSl9sUGdtR0wwdEFWLWdOVndrNHJkSHhDUGI5WFYwTklleGoyT2VxZUxVYlNZYTBTczlFaVdIV1FzMnM2SlAtUHhmTQ?oc=5","date":"2020-01-30","type":"deal","source":"GlobeNewswire","summary":"Amarantus Acquires Majority Interest in CBD Wellness Company Hempori - GlobeNewswire","headline":"Amarantus Acquires Majority Interest in CBD Wellness Company Hempori","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxPbUFMd1dOMTBTYUY4a0Rjc1RTZ3JFZXE1WFZnTmd0WE91UkFuaDFhc2V4OUg1V3g1cS13elBmd0xnd1RIVEdCMEJzS2hQX212ZHVlYnhsVi04akM4TVlSR3BKQlRKRjl5dk9uY3d3Q0xWRzdVNElIcHdEc2MyWkhrVld5UW1RdGkwV2Nj?oc=5","date":"2018-11-29","type":"deal","source":"Contract Pharma","summary":"Coeptis Pharma to Acquire Elto Pharma - Contract Pharma","headline":"Coeptis Pharma to Acquire Elto Pharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiakFVX3lxTE5udEk4dHRiVkQzakJWai1KMzlBTWhuTmtjMjVuc1JtSlpVLU9zVDZJQVFsQ0lUV2tzVU96eFREVzVLR2xrWVhlczNsMUVzYTZsOWpfNVRDUU8yY0xqTEg3Rm8ySHJvRE11SGc?oc=5","date":"2018-11-28","type":"trial","source":"BioSpace","summary":"Coeptis Pharma Buys Elto Pharma for Phase II Parkinson’s Asset - BioSpace","headline":"Coeptis Pharma Buys Elto Pharma for Phase II Parkinson’s Asset","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAJBVV95cUxQNkdSNFZPODlial9uT01JV3l0MlNjQUxJQUZlbUw4Y2g0S1VaM0hqSmdBSXJFZ3VhQndNTUhGckRrNHNQSUNWSTFsNTh1bGVWcDRJLUN0aGJhQ1BEczF4Q1I0YzFTaUZBSnJLR0Y0Zl90dGw0RDU5dTNyUzNDYnRLbVMwN3kwVnpDZVFhQjVfQXNMRXVDOTg2dFRkUzk3cjBfbzhRb3ItZ1VaM1ptN09iQ3R4aVFfTDZNQ0ZqTkxfYUNSZGxNSEw5V1QyTTNfdUZRMEU1S2kzQUQwOEQzMF9TRFU2dDZ6eGduSTY5TVF6UEJLRXRXaEdmbEFZckhmdGZWS1Z4bTZzM3FpMGhYT0ZwWnQ4VU93MWdy?oc=5","date":"2018-04-23","type":"pipeline","source":"GlobeNewswire","summary":"Cutanogen Appoints Richard Kagan, MD as Chief Medical Advisor - GlobeNewswire","headline":"Cutanogen Appoints Richard Kagan, MD as Chief Medical Advisor","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiUkFVX3lxTE4wVXZ1ODJMeHpCUm1SZVZfdnpiNlVXdk0xd2FGMjQyamZDMmdDZTBDYjhzQjRUTDBsZ3BkUGswM24yNG9jSXRnWUx1Ri0tQ1RtRmc?oc=5","date":"2017-05-30","type":"pipeline","source":"Yahoo Finance Australia","summary":"Elite Pharmaceuticals, Inc. (ELTP) stock price, news, quote and history - Yahoo Finance Australia","headline":"Elite Pharmaceuticals, Inc. (ELTP) stock price, news, quote and history","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiUkFVX3lxTFBVYnBGUkJ2SElfU1VGOEFLTk11ZjhfUGVKc19UdTVnVjF1V2pCZU13elkwcnNfVXprcDJWMkVkelRvSEhjZkREM1NjYzhfaWRQWlE?oc=5","date":"2017-05-20","type":"pipeline","source":"Yahoo! Finance Canada","summary":"PharmaCyte Biotech, Inc. (PMCB) Stock Price, News, Quote & History - Yahoo! Finance Canada","headline":"PharmaCyte Biotech, Inc. (PMCB) Stock Price, News, Quote & History - Yahoo! Finance Canada","sentiment":"neutral"},{"date":"2017-05-09","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: CURRENT REPORT","headline":"SEC 8-K: CURRENT REPORT","sentiment":"neutral"},{"date":"2017-04-17","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: CURRENT REPORT","headline":"SEC 8-K: CURRENT REPORT","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxQY0VKU09SRkdUU0JFcFhGNWFqLS1XWkd6SjZycjVuU25vaWhkZWdEQ09GeTQyUmJtaV80MUcyYklXY0F3d2Y2Wlg4eGhYM0RNNHVlQ1lGaXZnc3dINXJKaHVlUXczRmZvLXFjV0RiNWgzN29XbW1NS0FqQTNaTm5ueTFENEtGWmpZdnMxd3pFdVVIRGdweU92WThVVDFHa2t0MEJMQjVLazQ4SFVR?oc=5","date":"2015-06-12","type":"regulatory","source":"Parkinson's News Today","summary":"Melior Discovery Receives Patent Approval For Parkinson’s Disease Candidate - Parkinson's News Today","headline":"Melior Discovery Receives Patent Approval For Parkinson’s Disease Candidate - Parkinson's News Today","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMizAFBVV95cUxQT2dSd1FscGJxY1hhdE1JcVRSWFhkazRXazNGSlJZRU1iSm0xaVFBZ2c2QUdHYWFRLXVkeXdERFhhUUdRMHNleEVrWHNkdnVITlRvUzNreE1jTzc2RG1KMGhKMzdDYUg2bXJMSFJrQTl1VzFFbUNDMjJRQlVtTDlKV0wweWJTbDR2NUtaWllqdkhqcm40bDNiMERtYkJWVVRPS19UWTZ2RE5uSTU5U2hQdl9NV2pkbTB5VkZWQW1Xd1VxeU9mTzhmNnJxVXE?oc=5","date":"2015-03-03","type":"pipeline","source":"News-Medical","summary":"Regenicin receives final payment to conclude Asset Purchase Agreement with Amarantus - News-Medical","headline":"Regenicin receives final payment to conclude Asset Purchase Agreement with Amarantus - News","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiakFVX3lxTFAxOEMzSnA1TlA2bExPSnd3MnNYcmdTQXdEWHl6dE1Qa0p2MDNVaUtkakZfOERTN0h3LWlhY211TmxhUUZWQkFNR0lUcnNySnFGbUs3ZUl2UGgyWl8yZFdNSldEQi1aZmwxU2c?oc=5","date":"2013-01-01","type":"pipeline","source":"Genetic Engineering and Biotechnology News","summary":"People in the News - Genetic Engineering and Biotechnology News","headline":"People in the News","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_2":2},"enrichmentLevel":3,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":{"source":"sec_edgar+yahoo","revenue":0,"revenuePeriod":"2014-12-31","revenueHistory":[{"value":0,"period":"2014-12-31"},{"value":0,"period":"2013-12-31"},{"value":415996,"period":"2011-12-31"},{"value":192408,"period":"2010-12-31"}],"grossProfit":null,"grossProfitHistory":[],"rdSpend":13256000,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-25214000,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":176000,"cashHistory":[],"totalAssets":11771000,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[]},"ciks":null,"lastFiledAt":null},"yahoo":null}